Drug Trial Radar · NCT07903987
Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's Disease
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Dec 13, 2024
Primary completion
Aug 30, 2027
Study completion Sep 15, 2027
Sponsor
- Lead sponsor
- University Medical Center GroningenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- St. Antonius Hospital
- First posted
- Oct 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if FAPI-PET/CT and/or FDG-PET/CT scan is able to detect active fibroblast tissue and inflammation in patients with acute or chronic phase PD. * Does FAPI PET/CT scan or FDG PET/CT scan show any uptake of inflammatory tissue in patients with Peyronie's disease * Participants will undergo a FAPI PET/CT scan and FDG PET/CT scan after diagnosis of Peyronie's disease.
Conditions
- Peyronie's Disease
Interventions
68Ga-FAPI (gallium-68-labeled fibroblast activation protein inhibitor)Drug
1 dosage for PET/scan of 200 MBq
Primary outcomes
What the sponsor says the trial is designed to measure.
- In first ten PD patients detection of active fibroblasts (uptake of FAPI) and/or inflammation (uptake of FDG) in the penis with PET/CT scan. In second ten PD Patients no detection of chronic fibrotic tissue with FAPI and/or FDG uptake with PET/CT scan.Time frame: From enrollment to after the second PET/CT scan. The PET/CT Scan will be performed within 2 weeks after enrollment in the active phase. At least 24 hours between the two PET/CT scans. No timelimit in the chronic phase for first PET/CT scan.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St Antoniusziekenhuis
Nieuwegein, Utrecht, Netherlands · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.